Fas Ligand Protein

A transmembrane protein belonging to the tumor necrosis factor superfamily that was originally discovered on cells of the lymphoid-myeloid lineage, including activated T-LYMPHOCYTES and NATURAL KILLER CELLS. It plays an important role in immune homeostasis and cell-mediated toxicity by binding to the FAS RECEPTOR and triggering APOPTOSIS.

Also Known As:

Fas Ligand; CD178 Antigen; CD95 Antigen Ligand; CD95 Ligand; CD95L; Fas Ligand (FasL); FasL Protein; TNF Superfamily, Member 6; Antigen, CD178; Antigens, CD178; CD178 Antigens; Tumor Necrosis Factor Ligand Superfamily Member 6

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Fas Ligand Protein: 2703
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Tumor Necrosis Factors: 152
        Fas Ligand Protein: 2703
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Fas Ligand Protein: 2703
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Fas Ligand Protein: 2703
- Peptides: 82426
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Tumor Necrosis Factors: 152
        Fas Ligand Protein: 2703
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Cytokines: 164289
    - Tumor Necrosis Factors: 152
      - Fas Ligand Protein: 2703

R Drews Selected Research

R Drews Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure